Overview

Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted Conditions

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to prove the bioequivalence of Famciclovir 500 mg Tablets under fasting conditions.
Phase:
N/A
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
2-Aminopurine
Famciclovir